GenOway offers custom mouse models, and says deal will result in a more integrated offering.

French firms genOway and PhenoPro established a strategic alliance through which genOway will exclusively distribute PhenoPro’s services and expertise in mouse model phenotyping and phenogenomics. Established in 2007, Institut Clinique de la Souris spin-out PhenoPro claims to have one of the most advanced and complete phenotyping platforms, founded on the phenotyping of over 800 genetically modified lines over the last six years.

GenOway offers customized mouse models for the biopharma, chemical, agrochemical, and food industries, and for academic research. The firm says adding PhenoPro’s platform and expertise for customized phenotyping services will provide a more integrated offering for its clients.

“We have developed a unique technological platform to provide scientists with the most adapted and innovative genetically modified models,” comments Alexandre Fraichard, genOway CEO. “We made the strategic decision to expand this offer to the phenotyping of created models. PhenoPro was the best potential partner since their technologies are well-recognized by the scientific community and we share the same strategy: to develop the most adapted customer services.”

Previous articleRegeneron, Bayer Confirm Australian Approval of Eylea for Wet AMD
Next articleBellicum Raises $20M to Progress Cell Transplant and Cancer Vaccine Products